CD39 is upregulated in systemic lupus erythematosus (SLE) patients who exhibit increased levels of ATP that binds to P2X receptors resulting in activation of the inflammasome, release of IL-1β, and other cytokines associated with disease pathogenesis (72). This evidence concerns the gene ENTPD1 and systemic lupus erythematosus.